Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Walrath

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Advances in Cancer Research|April 20, 2010
Genetically engineered mouse models in cancer researchJessica C Walrath, Jessica J Hawes, Terry Van Dyke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2013
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvalsMichael B Shea, Samantha A Roberts, Jessica C Walrath, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 7, 2009
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific mannerJessica C Walrath, Kristi Fox, Erika Truffer, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Molecular Cancer Therapeutics|May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent mannerThomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
Nature Reviews. Drug Discovery|September 7, 2013
Considerations for the successful co-development of targeted cancer therapies and companion diagnosticsJane Fridlyand, Richard M Simon, Jessica C Walrath, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Advances in Cancer Research|April 20, 2010
Genetically engineered mouse models in cancer researchJessica C Walrath, Jessica J Hawes, Terry Van Dyke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2013
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvalsMichael B Shea, Samantha A Roberts, Jessica C Walrath, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 7, 2009
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific mannerJessica C Walrath, Kristi Fox, Erika Truffer, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Molecular Cancer Therapeutics|May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent mannerThomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
Nature Reviews. Drug Discovery|September 7, 2013
Considerations for the successful co-development of targeted cancer therapies and companion diagnosticsJane Fridlyand, Richard M Simon, Jessica C Walrath, et al.
Pageof 1